SKYE Market Cap History Table | ||||
Also see: SKYE Shares Outstanding History and SKYE YTD Return |
SKYE Market Cap History Table | ||||
Also see: SKYE Shares Outstanding History and SKYE YTD Return |
SKYE Market Cap History Chart | |||
Mouse over chart for data details
|
SKYE Stock Price Chart |
About Skye Bioscience Inc |
Skye Bioscience is a biopharmaceutical company focused on the discovery, development, and the commercialization of cannabinoid-based therapeutics through a number of license agreements with the University of Mississippi. Co.'s cannabinoid product candidates include NB1111, a prodrug of tetrahydrocannabinol indicated for glaucoma; NB2222, a prototype ocular formulation of the proprietary Co.'s cannabidiol analog, for the potential treatment and management of several eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy; and NB3111, which is undergoing testing as an anti-infective agent against Methicillin-resistant Staphylococcus aureus. We show 1 historical shares outstanding datapoints in our SKYE shares outstanding history coverage, used to compute SKYE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SKYE market cap history over the course of time is important for investors interested in comparing SKYE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SKYE versus a peer is one thing; comparing SKYE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SKYE can fluctuate over the course of history. With this page we aim to empower investors researching SKYE by allowing them to research the SKYE market cap history. |
SKYE Current Stock Quote |
Free SKYE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
SKYE Share Performance |
Market Cap Peers |
Skye Bioscience (SKYE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SLDB Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.